Your browser doesn't support javascript.
loading
Elevated levels of interleukin-18 are associated with several indices of general and visceral adiposity and insulin resistance in women with polycystic ovary syndrome.
Kabakchieva, Plamena; Gateva, Antoaneta; Velikova, Tsvetelina; Georgiev, Tsvetoslav; Yamanishi, Kyosuke; Okamura, Haruki; Kamenov, Zdravko.
Afiliación
  • Kabakchieva P; Clinic of Endocrinology, University Hospital "Alexandrovska", Department of Internal Medicine, Medical Faculty, Medical University of Sofia, Sofia, Bulgaria, plamenakabakchieva@yahoo.com.
  • Gateva A; Clinic of Internal Diseases, Naval Hospital - Varna, Military Medical Academy, Bulgaria.
  • Velikova T; Clinic of Endocrinology, University Hospital "Alexandrovska", Department of Internal Medicine, Medical Faculty, Medical University of Sofia, Sofia, Bulgaria.
  • Georgiev T; Laboratory of Clinical Immunology, University Hospital "Lozenetz", Medical Faculty, Sofia University "St. Kliment Ohridski", Sofia, Bulgaria.
  • Yamanishi K; University Hospital "St. Marina", First Department of Internal Medicine, Medical Faculty, Medical University - Varna, Varna, Bulgaria.
  • Okamura H; Department of Psychoimmunology, Hyogo College of Medicine, Japan.
  • Kamenov Z; Department of Psychoimmunology, Hyogo College of Medicine, Japan.
Arch Endocrinol Metab ; 66(1): 3-11, 2022 Mar 08.
Article en En | MEDLINE | ID: mdl-35263047
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Síndrome del Ovario Poliquístico / Resistencia a la Insulina / Interleucina-18 Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Arch Endocrinol Metab Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Síndrome del Ovario Poliquístico / Resistencia a la Insulina / Interleucina-18 Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Arch Endocrinol Metab Año: 2022 Tipo del documento: Article